カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経皮吸収型スキンパッチの世界市場見通し2023年-2029年

◆英語タイトル：Transdermal Skin Patch Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8717 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Transdermal Skin Patch Market 調査レポートは次の情報を含め、グローバルにおけるの経皮吸収型スキンパッチ市場規模と予測を収録しています。・世界の経皮吸収型スキンパッチ市場：売上、2018年-2023年、2024年-2029年
・世界の経皮吸収型スキンパッチ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経皮吸収型スキンパッチ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「フェンタニル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経皮吸収型スキンパッチのグローバル主要企業は、Hisamitsu Pharmaceutical、 Novartis、 Johnson & Johnson、 Teikoku Pharma、 Mylan、 Actavis、 Mundipharma、 Henan Lingrui Pharmaceutical、 Changzhou Siyao、 Rfl Pharmaceutical、 Luye Pharma Group Ltd.、 Purdue Pharma L.P.、 Teva Pharmaceutical Industries Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経皮吸収型スキンパッチのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経皮吸収型スキンパッチ市場：タイプ別、2018年-2023年、2024年-2029年
世界の経皮吸収型スキンパッチ市場：タイプ別市場シェア、2022年
・フェンタニル、ニコチン、クロニジン、ブプレノルフィン

世界の経皮吸収型スキンパッチ市場：用途別、2018年-2023年、2024年-2029年
世界の経皮吸収型スキンパッチ市場：用途別市場シェア、2022年
・痛み緩和、禁煙、過活動膀胱治療、その他

世界の経皮吸収型スキンパッチ市場：地域・国別、2018年-2023年、2024年-2029年
世界の経皮吸収型スキンパッチ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経皮吸収型スキンパッチのグローバル売上、2018年-2023年
・主要企業における経皮吸収型スキンパッチのグローバル売上シェア、2022年
・主要企業における経皮吸収型スキンパッチのグローバル販売量、2018年-2023年
・主要企業における経皮吸収型スキンパッチのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Hisamitsu Pharmaceutical、 Novartis、 Johnson & Johnson、 Teikoku Pharma、 Mylan、 Actavis、 Mundipharma、 Henan Lingrui Pharmaceutical、 Changzhou Siyao、 Rfl Pharmaceutical、 Luye Pharma Group Ltd.、 Purdue Pharma L.P.、 Teva Pharmaceutical Industries Ltd.

*************************************************************

・調査・分析レポートの概要
経皮吸収型スキンパッチ市場の定義
市場セグメント
世界の経皮吸収型スキンパッチ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経皮吸収型スキンパッチ市場規模
世界の経皮吸収型スキンパッチ市場規模：2022年 VS 2029年
世界の経皮吸収型スキンパッチ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経皮吸収型スキンパッチの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経皮吸収型スキンパッチ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：フェンタニル、ニコチン、クロニジン、ブプレノルフィン
経皮吸収型スキンパッチのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：痛み緩和、禁煙、過活動膀胱治療、その他
経皮吸収型スキンパッチの用途別グローバル売上・予測

・地域別市場分析
地域別経皮吸収型スキンパッチ市場規模 2022年と2029年
地域別経皮吸収型スキンパッチ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Hisamitsu Pharmaceutical、 Novartis、 Johnson & Johnson、 Teikoku Pharma、 Mylan、 Actavis、 Mundipharma、 Henan Lingrui Pharmaceutical、 Changzhou Siyao、 Rfl Pharmaceutical、 Luye Pharma Group Ltd.、 Purdue Pharma L.P.、 Teva Pharmaceutical Industries Ltd.
...

This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch. This report contains market size and forecasts of Transdermal Skin Patch in global, including the following market information:
Global Transdermal Skin Patch Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transdermal Skin Patch Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Transdermal Skin Patch companies in 2022 (%)
The global Transdermal Skin Patch market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Fentanyl Transdermal Skin Patch Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Skin Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Skin Patch Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, by Type, 2022 (%)
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Global Transdermal Skin Patch Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, by Application, 2022 (%)
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Global Transdermal Skin Patch Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Skin Patch revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transdermal Skin Patch revenues share in global market, 2022 (%)
Key companies Transdermal Skin Patch sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Transdermal Skin Patch sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Skin Patch, market overview.
Chapter 2: Global Transdermal Skin Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal Skin Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Transdermal Skin Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Skin Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Skin Patch Overall Market Size
2.1 Global Transdermal Skin Patch Market Size: 2022 VS 2029
2.2 Global Transdermal Skin Patch Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transdermal Skin Patch Sales: 2018-2029
3 Company Landscape
3.1 Top Transdermal Skin Patch Players in Global Market
3.2 Top Global Transdermal Skin Patch Companies Ranked by Revenue
3.3 Global Transdermal Skin Patch Revenue by Companies
3.4 Global Transdermal Skin Patch Sales by Companies
3.5 Global Transdermal Skin Patch Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal Skin Patch Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal Skin Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Skin Patch Players in Global Market
3.8.1 List of Global Tier 1 Transdermal Skin Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal Skin Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transdermal Skin Patch Market Size Markets, 2022 & 2029
4.1.2 Fentanyl Transdermal Skin Patch
4.1.3 Nicotine Transdermal Skin Patch
4.1.4 Clonidine Transdermal Skin Patch
4.1.5 Buprenorphine Transdermal Skin Patch
4.2 By Type – Global Transdermal Skin Patch Revenue & Forecasts
4.2.1 By Type – Global Transdermal Skin Patch Revenue, 2018-2023
4.2.2 By Type – Global Transdermal Skin Patch Revenue, 2024-2029
4.2.3 By Type – Global Transdermal Skin Patch Revenue Market Share, 2018-2029
4.3 By Type – Global Transdermal Skin Patch Sales & Forecasts
4.3.1 By Type – Global Transdermal Skin Patch Sales, 2018-2023
4.3.2 By Type – Global Transdermal Skin Patch Sales, 2024-2029
4.3.3 By Type – Global Transdermal Skin Patch Sales Market Share, 2018-2029
4.4 By Type – Global Transdermal Skin Patch Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transdermal Skin Patch Market Size, 2022 & 2029
5.1.2 Relieve Severe Pain
5.1.3 Stop Smoking Cigarettes
5.1.4 Treat an Overactive Bladder
5.1.5 Others
5.2 By Application – Global Transdermal Skin Patch Revenue & Forecasts
5.2.1 By Application – Global Transdermal Skin Patch Revenue, 2018-2023
5.2.2 By Application – Global Transdermal Skin Patch Revenue, 2024-2029
5.2.3 By Application – Global Transdermal Skin Patch Revenue Market Share, 2018-2029
5.3 By Application – Global Transdermal Skin Patch Sales & Forecasts
5.3.1 By Application – Global Transdermal Skin Patch Sales, 2018-2023
5.3.2 By Application – Global Transdermal Skin Patch Sales, 2024-2029
5.3.3 By Application – Global Transdermal Skin Patch Sales Market Share, 2018-2029
5.4 By Application – Global Transdermal Skin Patch Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transdermal Skin Patch Market Size, 2022 & 2029
6.2 By Region – Global Transdermal Skin Patch Revenue & Forecasts
6.2.1 By Region – Global Transdermal Skin Patch Revenue, 2018-2023
6.2.2 By Region – Global Transdermal Skin Patch Revenue, 2024-2029
6.2.3 By Region – Global Transdermal Skin Patch Revenue Market Share, 2018-2029
6.3 By Region – Global Transdermal Skin Patch Sales & Forecasts
6.3.1 By Region – Global Transdermal Skin Patch Sales, 2018-2023
6.3.2 By Region – Global Transdermal Skin Patch Sales, 2024-2029
6.3.3 By Region – Global Transdermal Skin Patch Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transdermal Skin Patch Revenue, 2018-2029
6.4.2 By Country – North America Transdermal Skin Patch Sales, 2018-2029
6.4.3 US Transdermal Skin Patch Market Size, 2018-2029
6.4.4 Canada Transdermal Skin Patch Market Size, 2018-2029
6.4.5 Mexico Transdermal Skin Patch Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transdermal Skin Patch Revenue, 2018-2029
6.5.2 By Country – Europe Transdermal Skin Patch Sales, 2018-2029
6.5.3 Germany Transdermal Skin Patch Market Size, 2018-2029
6.5.4 France Transdermal Skin Patch Market Size, 2018-2029
6.5.5 U.K. Transdermal Skin Patch Market Size, 2018-2029
6.5.6 Italy Transdermal Skin Patch Market Size, 2018-2029
6.5.7 Russia Transdermal Skin Patch Market Size, 2018-2029
6.5.8 Nordic Countries Transdermal Skin Patch Market Size, 2018-2029
6.5.9 Benelux Transdermal Skin Patch Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transdermal Skin Patch Revenue, 2018-2029
6.6.2 By Region – Asia Transdermal Skin Patch Sales, 2018-2029
6.6.3 China Transdermal Skin Patch Market Size, 2018-2029
6.6.4 Japan Transdermal Skin Patch Market Size, 2018-2029
6.6.5 South Korea Transdermal Skin Patch Market Size, 2018-2029
6.6.6 Southeast Asia Transdermal Skin Patch Market Size, 2018-2029
6.6.7 India Transdermal Skin Patch Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transdermal Skin Patch Revenue, 2018-2029
6.7.2 By Country – South America Transdermal Skin Patch Sales, 2018-2029
6.7.3 Brazil Transdermal Skin Patch Market Size, 2018-2029
6.7.4 Argentina Transdermal Skin Patch Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transdermal Skin Patch Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transdermal Skin Patch Sales, 2018-2029
6.8.3 Turkey Transdermal Skin Patch Market Size, 2018-2029
6.8.4 Israel Transdermal Skin Patch Market Size, 2018-2029
6.8.5 Saudi Arabia Transdermal Skin Patch Market Size, 2018-2029
6.8.6 UAE Transdermal Skin Patch Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Company Summary
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.1.5 Hisamitsu Pharmaceutical Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Transdermal Skin Patch Major Product Offerings
7.2.4 Novartis Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Transdermal Skin Patch Major Product Offerings
7.3.4 Johnson & Johnson Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Teikoku Pharma
7.4.1 Teikoku Pharma Company Summary
7.4.2 Teikoku Pharma Business Overview
7.4.3 Teikoku Pharma Transdermal Skin Patch Major Product Offerings
7.4.4 Teikoku Pharma Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.4.5 Teikoku Pharma Key News & Latest Developments
7.5 Mylan
7.5.1 Mylan Company Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Transdermal Skin Patch Major Product Offerings
7.5.4 Mylan Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.5.5 Mylan Key News & Latest Developments
7.6 Actavis
7.6.1 Actavis Company Summary
7.6.2 Actavis Business Overview
7.6.3 Actavis Transdermal Skin Patch Major Product Offerings
7.6.4 Actavis Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.6.5 Actavis Key News & Latest Developments
7.7 Mundipharma
7.7.1 Mundipharma Company Summary
7.7.2 Mundipharma Business Overview
7.7.3 Mundipharma Transdermal Skin Patch Major Product Offerings
7.7.4 Mundipharma Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.7.5 Mundipharma Key News & Latest Developments
7.8 Henan Lingrui Pharmaceutical
7.8.1 Henan Lingrui Pharmaceutical Company Summary
7.8.2 Henan Lingrui Pharmaceutical Business Overview
7.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.8.5 Henan Lingrui Pharmaceutical Key News & Latest Developments
7.9 Changzhou Siyao
7.9.1 Changzhou Siyao Company Summary
7.9.2 Changzhou Siyao Business Overview
7.9.3 Changzhou Siyao Transdermal Skin Patch Major Product Offerings
7.9.4 Changzhou Siyao Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.9.5 Changzhou Siyao Key News & Latest Developments
7.10 Rfl Pharmaceutical
7.10.1 Rfl Pharmaceutical Company Summary
7.10.2 Rfl Pharmaceutical Business Overview
7.10.3 Rfl Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.10.4 Rfl Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.10.5 Rfl Pharmaceutical Key News & Latest Developments
7.11 Luye Pharma Group Ltd.
7.11.1 Luye Pharma Group Ltd. Company Summary
7.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Business Overview
7.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Major Product Offerings
7.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.11.5 Luye Pharma Group Ltd. Key News & Latest Developments
7.12 Purdue Pharma L.P.
7.12.1 Purdue Pharma L.P. Company Summary
7.12.2 Purdue Pharma L.P. Transdermal Skin Patch Business Overview
7.12.3 Purdue Pharma L.P. Transdermal Skin Patch Major Product Offerings
7.12.4 Purdue Pharma L.P. Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.12.5 Purdue Pharma L.P. Key News & Latest Developments
7.13 Teva Pharmaceutical Industries Ltd.
7.13.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Business Overview
7.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales and Revenue in Global (2018-2023)
7.13.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Global Transdermal Skin Patch Production Capacity, Analysis
8.1 Global Transdermal Skin Patch Production Capacity, 2018-2029
8.2 Transdermal Skin Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal Skin Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal Skin Patch Supply Chain Analysis
10.1 Transdermal Skin Patch Industry Value Chain
10.2 Transdermal Skin Patch Upstream Market
10.3 Transdermal Skin Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal Skin Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Transdermal Skin Patch in Global Market
Table 2. Top Transdermal Skin Patch Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Transdermal Skin Patch Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Transdermal Skin Patch Revenue Share by Companies, 2018-2023
Table 5. Global Transdermal Skin Patch Sales by Companies, (K Units), 2018-2023
Table 6. Global Transdermal Skin Patch Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Transdermal Skin Patch Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Transdermal Skin Patch Product Type
Table 9. List of Global Tier 1 Transdermal Skin Patch Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Skin Patch Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Transdermal Skin Patch Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Transdermal Skin Patch Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Transdermal Skin Patch Sales (K Units), 2018-2023
Table 15. By Type - Global Transdermal Skin Patch Sales (K Units), 2024-2029
Table 16. By Application – Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Transdermal Skin Patch Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Transdermal Skin Patch Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Transdermal Skin Patch Sales (K Units), 2018-2023
Table 20. By Application - Global Transdermal Skin Patch Sales (K Units), 2024-2029
Table 21. By Region – Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Transdermal Skin Patch Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Transdermal Skin Patch Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Transdermal Skin Patch Sales (K Units), 2018-2023
Table 25. By Region - Global Transdermal Skin Patch Sales (K Units), 2024-2029
Table 26. By Country - North America Transdermal Skin Patch Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Transdermal Skin Patch Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Transdermal Skin Patch Sales, (K Units), 2018-2023
Table 29. By Country - North America Transdermal Skin Patch Sales, (K Units), 2024-2029
Table 30. By Country - Europe Transdermal Skin Patch Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Transdermal Skin Patch Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Transdermal Skin Patch Sales, (K Units), 2018-2023
Table 33. By Country - Europe Transdermal Skin Patch Sales, (K Units), 2024-2029
Table 34. By Region - Asia Transdermal Skin Patch Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Transdermal Skin Patch Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Transdermal Skin Patch Sales, (K Units), 2018-2023
Table 37. By Region - Asia Transdermal Skin Patch Sales, (K Units), 2024-2029
Table 38. By Country - South America Transdermal Skin Patch Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Transdermal Skin Patch Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Transdermal Skin Patch Sales, (K Units), 2018-2023
Table 41. By Country - South America Transdermal Skin Patch Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Transdermal Skin Patch Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Transdermal Skin Patch Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Transdermal Skin Patch Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Transdermal Skin Patch Sales, (K Units), 2024-2029
Table 46. Hisamitsu Pharmaceutical Company Summary
Table 47. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Offerings
Table 48. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Hisamitsu Pharmaceutical Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Transdermal Skin Patch Product Offerings
Table 52. Novartis Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Transdermal Skin Patch Product Offerings
Table 56. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Teikoku Pharma Company Summary
Table 59. Teikoku Pharma Transdermal Skin Patch Product Offerings
Table 60. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Teikoku Pharma Key News & Latest Developments
Table 62. Mylan Company Summary
Table 63. Mylan Transdermal Skin Patch Product Offerings
Table 64. Mylan Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Mylan Key News & Latest Developments
Table 66. Actavis Company Summary
Table 67. Actavis Transdermal Skin Patch Product Offerings
Table 68. Actavis Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Actavis Key News & Latest Developments
Table 70. Mundipharma Company Summary
Table 71. Mundipharma Transdermal Skin Patch Product Offerings
Table 72. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Mundipharma Key News & Latest Developments
Table 74. Henan Lingrui Pharmaceutical Company Summary
Table 75. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Offerings
Table 76. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Henan Lingrui Pharmaceutical Key News & Latest Developments
Table 78. Changzhou Siyao Company Summary
Table 79. Changzhou Siyao Transdermal Skin Patch Product Offerings
Table 80. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Changzhou Siyao Key News & Latest Developments
Table 82. Rfl Pharmaceutical Company Summary
Table 83. Rfl Pharmaceutical Transdermal Skin Patch Product Offerings
Table 84. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Rfl Pharmaceutical Key News & Latest Developments
Table 86. Luye Pharma Group Ltd. Company Summary
Table 87. Luye Pharma Group Ltd. Transdermal Skin Patch Product Offerings
Table 88. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Luye Pharma Group Ltd. Key News & Latest Developments
Table 90. Purdue Pharma L.P. Company Summary
Table 91. Purdue Pharma L.P. Transdermal Skin Patch Product Offerings
Table 92. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Purdue Pharma L.P. Key News & Latest Developments
Table 94. Teva Pharmaceutical Industries Ltd. Company Summary
Table 95. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Offerings
Table 96. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 98. Transdermal Skin Patch Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Transdermal Skin Patch Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Transdermal Skin Patch Production by Region, 2018-2023 (K Units)
Table 101. Global Transdermal Skin Patch Production by Region, 2024-2029 (K Units)
Table 102. Transdermal Skin Patch Market Opportunities & Trends in Global Market
Table 103. Transdermal Skin Patch Market Drivers in Global Market
Table 104. Transdermal Skin Patch Market Restraints in Global Market
Table 105. Transdermal Skin Patch Raw Materials
Table 106. Transdermal Skin Patch Raw Materials Suppliers in Global Market
Table 107. Typical Transdermal Skin Patch Downstream
Table 108. Transdermal Skin Patch Downstream Clients in Global Market
Table 109. Transdermal Skin Patch Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Transdermal Skin Patch Segment by Type in 2022
Figure 2. Transdermal Skin Patch Segment by Application in 2022
Figure 3. Global Transdermal Skin Patch Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal Skin Patch Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transdermal Skin Patch Revenue, 2018-2029 (US$, Mn)
Figure 7. Transdermal Skin Patch Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2022
Figure 9. By Type - Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 11. By Type - Global Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 12. By Type - Global Transdermal Skin Patch Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 15. By Application - Global Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 16. By Application - Global Transdermal Skin Patch Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Transdermal Skin Patch Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Transdermal Skin Patch Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 20. By Region - Global Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 21. By Country - North America Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 22. By Country - North America Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 23. US Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 28. Germany Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 29. France Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 37. China Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 41. India Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 43. By Country - South America Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 44. Brazil Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Transdermal Skin Patch Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Transdermal Skin Patch Sales Market Share, 2018-2029
Figure 48. Turkey Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Transdermal Skin Patch Revenue, (US$, Mn), 2018-2029
Figure 52. Global Transdermal Skin Patch Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Transdermal Skin Patch by Region, 2022 VS 2029
Figure 54. Transdermal Skin Patch Industry Value Chain
Figure 55. Marketing Channels

※参考情報

経皮吸収型スキンパッチ、すなわちトランスダーマルスキンパッチは、特に医療や薬物療法の分野において重要な役割を果たす技術です。これらのパッチは皮膚を通じて有効成分を体内に直接供給する方式であり、従来の経口投与や注射と比べて多くの利点があります。

まず、経皮吸収型スキンパッチの定義について考えます。スキンパッチは、皮膚の表面に貼り付ける形状を持ち、一定の速度で薬剤を皮膚を介して放出し、内因的または外因的な作用を発揮するデリバリーデバイスです。これにより、患者は薬を簡便に使用できるだけでなく、投与のタイミングや頻度を自分で管理することが可能となります。

スキンパッチにはいくつかの特徴があります。第一に、持続的な薬物放出が可能である点です。経皮吸収型パッチは、数時間から数日間にわたり、一定の量の薬剤を皮膚を通じて放出することができます。これにより、血中濃度の変動を抑え、安定した治療効果を得ることができます。

次に、患者のコンプライアンスの向上が挙げられます。経皮投与方式は、患者にとって簡便で痛みが少ないため、特に長期的な治療が求められる場合に有効です。さらに、パッチは目に見えない形で服用できるため、心理的なストレスを軽減することができます。

経皮吸収型スキンパッチの種類には、主に以下のようなものがあります。オスマトリックポンプ型、マトリックス型、マニピュレーテッドペーパー型などがその代表です。オスマトリックポンプ型は、薬剤の放出速度を制御するために、浸透圧の差を利用しているデバイスです。マトリックス型は、薬剤を均一に分散させている基材を使用し、薬剤が徐々に放出される仕組みです。マニピュレーテッドペーパー型は、ペーパーの構成によって作られ、単純な構造である一方、柔軟性を有し、様々な形状に対応できます。

経皮吸収型スキンパッチの用途としては、疼痛管理やホルモン療法、精神神経疾患の治療などが挙げられます。例えば、疼痛管理のためには、モルヒネやフェンタニルなどのオピオイド製剤を含むパッチが使用されることが多く、これにより患者は痛みを軽減しながら、生活の質を向上させることができます。また、ホルモン療法においては、女性の更年期症状の緩和や避妊治療に使われるエストロゲンやプロゲステロンを含むパッチも広く利用されています。

関連技術としては、経皮吸収を促進するための手法や装置が存在します。たとえば、超音波や電気的手法を用いて、薬剤の皮膚透過性を向上させる技術が開発されています。超音波を使用することで、皮膚の角質層を擾乱し、薬剤の浸透性を高めます。また、イオントフォレシスという電気的手法を用いれば、薬剤に電気的な刺激を与え、皮膚を通じた吸収を促進することが可能です。

経皮吸収型スキンパッチの製造は、非常に高い技術力を要求されます。製造工程では、薬剤の安定性や放出特性を考慮して、様々な材料が選ばれます。例えば、ポリマー材料は薬剤を保持しつつ、必要な性能を維持するために重要となります。さらに、製品の安全性や品質管理も重要であり、厳格な規制に基づいた承認プロセスが必要です。

一方で、経皮吸収型スキンパッチにもいくつかの課題があります。皮膚の状態や被膜の厚さによって薬剤の吸収率が変動するため、個人差が大きいことが問題視されています。また、皮膚のアレルギー反応や刺激を引き起こす可能性があるため、安全性の観点からも注意が必要です。

最近では、さらなる進展が期待されている分野であり、スマートスキンパッチの開発も進んでいます。これらのパッチは、生体信号をリアルタイムでモニタリングし、患者の状態に応じて薬剤の放出を調整することが可能です。これにより、より個別化された医療が実現することが期待されています。

経皮吸収型スキンパッチは、今後の医療においてますます重要な役割を果たすことが予想されます。その快適さと利便性から、患者の治療への貢献は計り知れません。技術の進展とともに、さらなる理解と利用が進むことが期待されます。これにより、安全かつ効果的な治療方法として、経皮吸収型スキンパッチの需要が高まることでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経皮吸収型スキンパッチの世界市場見通し2023年-2029年(Transdermal Skin Patch Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経皮吸収型スキンパッチの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp